Chronic Kidney Disease (CKD)NCT07493642
Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
A study testing Multimedia Health Education and Standard Education Group in people with Chronic Kidney Disease (CKD) and CKD Stage 1-3, run by Fu Jen Catholic University Hospital at 1 site in Taiwan.
Trial summary
This clinical trial aims to determine whether a multimedia educational intervention can effectively improve physical fitness and physical activity levels in patients with chronic kidney disease (CKD), while also evaluating its overall outcomes. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Chronic Kidney Disease (CKD), CKD Stage 1-3
- What is being tested?
- Multimedia Health Education and Standard Education Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTaiwan
- Study dates
- 17 Nov 2025to 31 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Conscious adults aged 20 years or older who are literate and able to communicate in Mandarin or Taiwanese.
- Diagnosed with chronic kidney disease (CKD) stage 1 to 3b according to the CKD-EPI formula and confirmed by a nephrologist.
- Able to operate a mobile device (such as a smartphone, tablet, or computer) and have access to equipment capable of playing multimedia videos; family members or caregivers may assist if necessary.
- Able to view and understand multimedia educational video content.
Who cannot join
- Individuals with cognitive or psychiatric disorders that prevent understanding or adherence to the exercise program.
- Individuals with gait instability or limb amputation who are unable to perform the exercise protocol.
- Individuals with poorly controlled cardiovascular disease, such as heart failure, myocardial infarction, angina, arrhythmia, or those who have experienced chest pain during activity or rest within the past three months.
- Individuals deemed unsuitable for exercise by their attending physician.
- Individuals with poorly controlled diabetes (HbA1C > 9%) accompanied by retinopathy or foot ulcers.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
Fu Jen Catholic University Hospital
New Taipei City, Taishan District, 243
HUEI SHIN WEN, +886963012591, cvicky851122@gmail.com
About this study
This clinical trial aims to determine whether a multimedia educational intervention can effectively improve physical fitness and physical activity levels in patients with chronic kidney disease (CKD), while also evaluating its overall outcomes.
The study primarily seeks to answer the following questions:
Read more
- Can multimedia education enhance CKD patients' cardiorespiratory endurance, muscle strength, flexibility, and physical activity levels?
- Do patients receiving multimedia education demonstrate greater improvements in health behavior and fitness compared to those receiving standard education alone?
Researchers will compare a multimedia educational video program with conventional patient education to assess whether the multimedia approach helps patients maintain regular exercise and improve physical performance.
Participants will:
- Be randomly assigned to either the multimedia education group or the standard education group.
- Take part in a 12-week intervention and assessment period.
- Undergo pre- and post-intervention evaluations, including:
- Six-minute walk test, grip strength and chair-stand test, flexibility test, and body composition analysis (BMI, waist-to-hip ratio, InBody).
- Completion of a physical activity questionnaire (IPAQ-C). The findings will be used to evaluate the clinical value of multimedia education in CKD management and to support the development of effective patient exercise education programs.
- Conditions
- Chronic Kidney Disease (CKD), CKD Stage 1-3
- Being tested
- Multimedia Health Education, Standard Education Group
- Medical subject headings
- Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multimedia Health EducationBehavioural
Participants in this group will receive a multimedia exercise education program designed for patients with chronic kidney disease (CKD). The program includes instructional videos demonstrating proper exercise techniques, safety guidelines, and motivational content to encourage regular physical activity. The intervention aims to enhance participants' exercise knowledge, physical fitness, and activity levels over a 12-week period.
Standard Education GroupBehavioural
Standard CKD Education
| Study group | Role | What they receive |
|---|---|---|
| Multimedia Health Education | Experimental | Not described Receives: Behavioral: Multimedia Health Education |
| Standard Education Group | Active comparator | Standard CKD Education Receives: Behavioral: Standard Education Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in 6-minute walk test distance from baseline to 12 weeks, measured in meters.
Measured: Baseline and 12 weeks after intervention
Secondary outcomes (7)
Physical activity level (IPAQ-C)
Change in physical activity level measured by the International Physical Activity Questionnaire - Chinese version (IPAQ-C) from baseline to 12 weeks. Total physical activity will be expressed in metabolic equivalent task minutes per week (MET-min/week), with higher scores indicating higher levels of physical activity.
Measured: Baseline and 12 weeks after intervention
Change in handgrip strength from baseline to 12 weeks, measured in kilograms.
Measured: Baseline and 12 weeks after intervention
Change in chair stand test performance from baseline to 12 weeks, measured by number of repetitions completed in 30 seconds.
Measured: Baseline and 12 weeks after intervention
Change in sit-and-reach test score from baseline to 12 weeks, measured in centimeters.
Measured: Baseline and 12 weeks after intervention
Change in waist-to-hip ratio from baseline to 12 weeks.
Measured: Baseline and 12 weeks after intervention
Change in body mass index from baseline to 12 weeks, measured in kg/m².
Measured: Baseline and 12 weeks after intervention
Change in body composition from baseline to 12 weeks, including body fat percentage and skeletal muscle mass.
Measured: Baseline and 12 weeks after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2026
- Study start17 Nov 2025
- Primary completion30 Jun 2026 (estimated)
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Kidney Disease (CKD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fu Jen Catholic University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07493642
- Sponsor's protocol ID
- FJUH114494
- Status last verified
- Nov 2025
- First submitted
- 4 Mar 2026
- Last updated
- 25 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
- ClinicalTrials.gov ID
- NCT07493642
- Acronym / sponsor ID
- FJUH114494
- Conditions
- Chronic Kidney Disease (CKD), CKD Stage 1-3
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Fu Jen Catholic University HospitalUniversity, hospital or other
- Study start
- 17 Nov 2025 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 25 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical trial aims to determine whether a multimedia educational intervention can effectively improve physical fitness and physical activity levels in patients with chronic kidney disease (CKD), while also evaluating its overall outcomes.
The study primarily seeks to answer the following questions:
- Can multimedia education enhance CKD patients' cardiorespiratory endurance, muscle strength, flexibility, and physical activity levels?
- Do patients receiving multimedia education demonstrate greater improvements in health behavior and fitness compared to those receiving standard education alone?
Researchers will compare a multimedia educational video program with conventional patient education to assess whether the multimedia approach helps patients maintain regular exercise and improve physical performance.
Participants will:
- Be randomly assigned to either the multimedia education group or the standard education group.
- Take part in a 12-week intervention and assessment period.
- Undergo pre- and post-intervention evaluations, including:
- Six-minute walk test, grip strength and chair-stand test, flexibility test, and body composition analysis (BMI, waist-to-hip ratio, InBody).
- Completion of a physical activity questionnaire (IPAQ-C). The findings will be used to evaluate the clinical value of multimedia education in CKD management and to support the development of effective patient exercise education programs.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Multimedia Health Education | Experimental | Behavioral: Multimedia Health Education |
| Standard Education Group | Active comparator | Behavioral: Standard Education GroupStandard CKD Education |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Conscious adults aged 20 years or older who are literate and able to communicate in Mandarin or Taiwanese.
- Diagnosed with chronic kidney disease (CKD) stage 1 to 3b according to the CKD-EPI formula and confirmed by a nephrologist.
- Able to operate a mobile device (such as a smartphone, tablet, or computer) and have access to equipment capable of playing multimedia videos; family members or caregivers may assist if necessary.
- Able to view and understand multimedia educational video content.
Key exclusion criteria (5 listed)
- Individuals with cognitive or psychiatric disorders that prevent understanding or adherence to the exercise program.
- Individuals with gait instability or limb amputation who are unable to perform the exercise protocol.
- Individuals with poorly controlled cardiovascular disease, such as heart failure, myocardial infarction, angina, arrhythmia, or those who have experienced chest pain during activity or rest within the past three months.
- Individuals deemed unsuitable for exercise by their attending physician.
- Individuals with poorly controlled diabetes (HbA1C > 9%) accompanied by retinopathy or foot ulcers.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multimedia Health EducationParticipants in this group will receive a multimedia exercise education program designed for patients with chronic kidney disease (CKD). The program includes instructional videos demonstrating proper exercise techniques, safety guidelines, and motivational content to encourage regular physical activity. The intervention aims to enhance participants' exercise knowledge, physical fitness, and activity levels over a 12-week period. | Behavioural | Multimedia Health Education |
| Standard Education GroupStandard CKD Education | Behavioural | Standard Education Group |
Primary outcome
Change in 6-minute walk test distance from baseline to 12 weeks, measured in meters.
Time frame: Baseline and 12 weeks after intervention
7 secondary outcomes
Physical activity level (IPAQ-C)
Time frame: Baseline and 12 weeks after intervention
Change in handgrip strength from baseline to 12 weeks, measured in kilograms.
Time frame: Baseline and 12 weeks after intervention
Change in chair stand test performance from baseline to 12 weeks, measured by number of repetitions completed in 30 seconds.
Time frame: Baseline and 12 weeks after intervention
Change in sit-and-reach test score from baseline to 12 weeks, measured in centimeters.
Time frame: Baseline and 12 weeks after intervention
Change in waist-to-hip ratio from baseline to 12 weeks.
Time frame: Baseline and 12 weeks after intervention
Change in body mass index from baseline to 12 weeks, measured in kg/m².
Time frame: Baseline and 12 weeks after intervention
Change in body composition from baseline to 12 weeks, including body fat percentage and skeletal muscle mass.
Time frame: Baseline and 12 weeks after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Mar 2026.
Related trials for Chronic Kidney Disease (CKD)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruiting
An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care
Chronic Kidney Diseases
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
RecruitingObservational study
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Chronic Kidney Disease, Type 2 Diabetes Mellitus
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Chronic Kidney Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multimedia Health Education and Standard Education Group in people with Chronic Kidney Disease (CKD) and CKD Stage 1-3, run by Fu Jen Catholic University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact HUEI SHIN WEN (+886963012591, cvicky851122@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in 6-minute walk test distance from baseline to 12 weeks, measured in meters. (time frame: Baseline and 12 weeks after intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2026.